In agreement with our findings, recent studies have suggested that high EHD1 expression predicts a poor prognosis in lung cancer,32, 33 osteosarcoma23 and breast cancer,25 suggesting that EHD1 could serve as a potential therapeutic target. Here, EHD1 is linked to breast cancer.